Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease
Smet, M.H.; Marchal, G.; Lambert, L.; Devlieger, H.; Gewillig, M.
Journal Belge de Radiologie 72(5): 377-380
1989
ISSN/ISBN: 0302-7430 PMID: 2600053 Document Number: 327675
Prostaglandin E1 (PGE1) is an essential drug for infants with ductal-dependent congenital heart disease. Cortical hyperostosis of the long bones is one of the complications during and after PGE1 therapy and should be considered in the differential diagnosis of periostitis in the infant.